Combination therapy for advanced lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a combination of chemotherapy, immunotherapy, and carbon ion radiation for people with non-small cell lung cancer that cannot be removed by surgery and has not spread to other parts of the body. It aims to see if this approach is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer that has not spread beyond the chest and cannot be surgically removed.
- You have not received any prior treatment for this cancer.
- You do not have other serious health conditions or major organ problems.
- You do not have an active autoimmune disease (like lupus or rheumatoid arthritis) or a history of one.
- Your cancer does not have mutations in the EGFR, ALK, or ROS-1 genes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give radiation therapy (carbon ion boost) to people with advanced, inoperable lung cancer. The goal is to see if targeting the most aggressive parts of the tumor with a higher dose can improve outcomes.
This trial tests a new combination of immunotherapy and chemotherapy before and after standard chemoradiation for patients with stage III lung cancer that cannot be surgically removed. The goal is to see if this approach improves outcomes compared to chemoradiation alone.
This trial tests whether carbon ion radiation (high-energy targeted radiation) can control peripheral non-small cell lung cancer in people who are medically unable to have surgery. It may help shrink or stop tumor growth while limiting harm to nearby organs.
This trial studies a treatment plan that combines chemotherapy, immunotherapy, and radiation to the chest for people with unresectable stage III non-small-cell lung cancer (NSCLC). It may help by delivering anti-cancer drugs while also shrinking tumors with targeted radiation, especially for people who are not able to have the standard “chemo and radiation at the same time.”
This study tests whether adding focused radiation therapy to immunotherapy can help patients with advanced non-small cell lung cancer whose cancer has progressed despite prior immunotherapy. The goal is to see if this combination works better than immunotherapy alone.
This trial tests a new approach for advanced non-small cell lung cancer that cannot be surgically removed. It combines a focused, high-dose radiation treatment to the tumor core followed by standard chemotherapy and radiation together. This may help fight the cancer more effectively.
Hear when a new Carbon Ion Radiotheray trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.